JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF (JREE.SW) Stock Overview
Explore JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF’s financial performance, market position, analyst ratings, and future outlook.
JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF (JREE.SW)
Key Financials
Key Financials
Market Cap
1.8B
P/E Ratio
N/A
EPS (TTM)
$2.64
ROE
N/A
JREE.SW Stock Analysis & Investment Overview (SIX)
Our AI-powered analysis of JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF (SIX: JREE.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of JREE.SW on the SIX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $51.28 for the SIX listing.
Key metrics behind JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity Active UCITS ETF's SIX-traded stock include a P/E ratio of N/A and a market capitalization of 1.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of JREE.SW on the SIX.